Chandan Healthcare (NSE:CHANDAN) Growth Rank: 0 (As of Jun. 24, 2026)


NSE:CHANDAN Chandan Healthcare Ltd NSE:CHANDAN
17 GF Score
Price ₹220.85
! 4 Warning Signs
View Full Analysis

What is Chandan Healthcare Growth Rank?

Chandan Healthcare has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Chandan Healthcare Growth Rank Related Terms

NSE:CHANDAN
17GF Score
Chandan Healthcare Ltd NSE:CHANDAN
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chandan Healthcare Business Description

Address Kursi Road, Biotech Park, Sector G, Jankipuram, Lucknow, UP, IND, 226021
Chandan Healthcare Ltd operates laboratories that offer comprehensive pathological investigations. Its services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provide an extensive array of radiology services, including CT scans, X-rays, and MRIs. The company operates single reportable business segment that is Diagnostics Services.
17GF Score

Get the complete analysis for NSE:CHANDAN

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹220.85
Price